Skip to content

Kura Oncology, Inc.

KURA · XNAS

CIK 1422143fmd_07WE19YX43GJTF2D9YBHMTGS0FManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2007 to Sep 30, 2026, 69 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading